Risk factor profile and management of cerebrovascular patients in the REACH registry

Cerebrovascular Diseases

Volumn 25, Issue 4, 2008, Pages 366-374

  Röther, Joachim ^a,q   Alberts, Mark J ^b   Touzé, Emmanuel ^h   Mas, Jean Louis ^h   Hill, Michael D ^j   Michel, Patrik ^k   Bhatt, Deepak L ^c   Aichner, Franz T ^p   Goto, Shinya ^o   Matsumoto, Masayasu ^l   Ohman, E Magnus ^d   Okada, Yasushi ^m   Uchiyama, Shinichiro ⁿ   D'Agostino, Ralph ^e   Hirsch, Alan T ^f   Wilson, Peter W F ^g   Steg, P Gabriel ⁱ  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Duke Medical University   (United States)

^e BOSTON UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ BICHAT HOSPITAL   (France)

^j UNIVERSITY OF CALGARY   (Canada)

^k LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^l HIROSHIMA UNIVERSITY   (Japan)

^m NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

ⁿ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^o TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^p KEPLER UNIVERSITY HOSPITAL   (Austria)

^q KLINIKUM MINDEN   (Germany)

more..

Author keywords

Atherothrombosis; Cerebrovascular disease, risk factors; Epidemiology; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERY DISEASE; ARTERY THROMBOSIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DRUG USE; FEMALE; GENERAL PRACTITIONER; HEALTH PRACTITIONER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTICOAGULANTS; CEREBROVASCULAR DISORDERS; FEMALE; GUIDELINES AS TOPIC; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RISK FACTORS; STROKE; WORLD HEALTH;

EID: 42349086464     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000120687     Document Type: Article

References (34)

1. Fuster V: Atherothrombosis: mechanisms and clinical therapeutic approaches. Vasc Med 1998;3:231-239.
2. World Health Organization: The World Health Report 2002. Geneva, World Health Organization, 2002.
3. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P: Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
4. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC: Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001;32:2559-2566.
5. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
6. Gil-Nunez AC, Vivancos-Mora J: Blood pressure as a risk factor for stroke and the impact of antihypertensive treatment. Cerebrovasc Dis 2005;20(suppl 2):40-52.
7. Lewington S, MacMahon S: Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration. Am J Hypertens 1999;12:96S-98S.
8. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
9. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in highrisk patients. N Engl J Med 2000;342:145-153.
10. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
11. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
12. Anderson GF, Chu E: Expanding priorities - confronting chronic disease in countries with low income. N Engl J Med 2007;356:209-211.
13. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, Mas JL, Richard AJ, Rother J, Wilson PW: The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 2006;151:786. e1-786.e10.
14. Rother J, Steg PG, Ohman EM, Bhatt DL, Wilson PWF: Atherothrombosis and Stroke - a lot more to know! Announcement of an international, prospective registry in subjects at risk of atherothrombotic events in an outpatient setting - the REACH Registry. Cerebrovasc Dis 2005;20:139-140.
15. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-189.
16. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-1206.
17. Johnston SC, Smith WS: Practice variability in management of transient ischemic attacks. Eur Neurol 1999;42:105-108.
18. Daffertshofer M, Mielke O, Pullwitt A, Felsenstein M, Hennerici M: Transient ischemic attacks are more than 'ministrokes'. Stroke 2004;35:2453-2458.
19. Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901-2906.
20. Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, Mehta Z: A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005;366:29-36.
21. Rothwell PM, Warlow CP: Timing of TIAs preceding stroke: time window for prevention is very short. Neurology 2005;64:817-820.
22. Rothwell PM, Buchan A, Johnston SC: Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006;5:323-331.
23. Grobbee DE, Koudstaal PJ, Bots ML, Amaducci LA, Elwood PC, Ferro J, Freire de Concalves A, Kruger O, Inzitari D, Nikitin Y, Salonen JT, Sivenius J, Scheuermann W, Thelle DS, Trichopoulou A, Tuomilehto JT: Incidence and risk factors of ischaemic and haemorrhagic stroke in Europe - EUROSTROKE: a collaborative study among research centres in Europe: rationale and design. Neuroepidemiology 1996;15:291-300.
24. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA: American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke: risk factors. Stroke 1997;28:1507-1517.
25. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective Studies Collaboration. Lancet 1995;346:1647-1653.
26. Patel A, Woodward M, Campbell DJ, Sullivan DR, Colman S, Chalmers J, Neal B, MacMahon S: Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. Eur Heart J 2005;26:1910-1915.
27. Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire de Concalves A, Inzitari D, Sivenius J, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE: Total and HDL cholesterol and risk of stroke - EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 2002;56(suppl1):i19-i24.
28. Ebrahim S, Sung J, Song YM, Ferrer RL, Lawlor DA, Davey Smith G: Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ 2006;333:22.
29. Horenstein RB, Smith DE, Mosca L: Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke 2002;33:1863-1868.
30. Wannamethee SG, Shaper AG, Ebrahim S: HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000;31:1882-1888.
31. Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, Paik MC: Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003;34:1586-1592.
32. Hamann GF, Weimar C, Glahn J, Busse O, Diener HC: Adherence to secondary stroke prevention strategies - results from the German Stroke Data Bank. Cerebrovasc Dis 2003;15:282-288.
33. Amarenco P, Labreuche J, Lavallee P, Touboul PJ: Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-2909.
34. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.